Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04421573 · ClinicalTrials.gov registry record · NA

Cervical Plexus Hydrodissection With D5W for PTSD

A NA study of PTSD, sponsored by Dr. Dean Reeves Clinic.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
4
Study locations

NCT04421573 is a NA study of PTSD that is actively recruiting participants, run by Dr. Dean Reeves Clinic. The registered enrollment target is 24 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04421573, a NA study of PTSD, is actively recruiting participants, sponsored by Dr. Dean Reeves Clinic.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
4
Study locations

Study Summary

PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with a delayed/usual treatment control.

Conditions Studied

Interventions

  • PROCEDURE BCPHD with D5W
  • PROCEDURE Waiting period with usual care

Study Locations (4)

Oregon

  • Paul W. Johnson, D.O., Clinic. - Portland
  • NW Regen - Tigard

Kentucky

  • Danesh Mazloomdoost - Lexington

Wisconsin

  • Eric Phillippi M.D. Clinic - Madison

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-07-10
Est. Completion 2027-10-01
Phase NA

Sponsor

Dr. Dean Reeves Clinic

4 total trials

What the Registry Record Tells You About NCT04421573

The ClinicalTrials.gov registry entry for NCT04421573 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (92% lower). The listed sponsor is Dr. Dean Reeves Clinic, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which BCPHD with D5W is the first listed.

NCT04421573 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Oregon, Kentucky, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT04421573 about?

NCT04421573 is a clinical study titled "Cervical Plexus Hydrodissection With D5W for PTSD". PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PT...

What is the current status of trial NCT04421573?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2023-07-10. Estimated completion is 2027-10-01.

What conditions does trial NCT04421573 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT04421573?

The interventions under investigation include: BCPHD with D5W (PROCEDURE), Waiting period with usual care (PROCEDURE).

Who is sponsoring clinical trial NCT04421573?

This trial is sponsored by Dr. Dean Reeves Clinic, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04421573 being conducted?

This trial has 4 study locations across Kentucky, Oregon, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.